# MK0954A-264 Filter Study (0954A-264)(COMPLETED)

> **NCT00307060** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 274 (actual)

## Conditions studied

- Mild to Severe Hypertension

## Interventions

- **DRUG:** MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks
- **DRUG:** losartan / Duration of Treatment: 6 weeks

## Key facts

- **NCT ID:** NCT00307060
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-01
- **Primary completion:** 2005-06-01
- **Final completion:** 2005-06-02
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307060, "MK0954A-264 Filter Study (0954A-264)(COMPLETED)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00307060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*